Company profile for Leucid Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Leucid Bio is a clinical-stage biotechnology company pioneering next-generation cell therapies for hard-to-treat cancers, particularly solid tumors. Founded in 2014 to translate over 20 years of CAR-T research led by Dr. John Maher at King's College London, Leucid has developed a proprietary Lateral CAR platform. This platform redesigns CAR structures to mimic natural immune receptor configurations, enhancing T-cell potency an...
Leucid Bio is a clinical-stage biotechnology company pioneering next-generation cell therapies for hard-to-treat cancers, particularly solid tumors. Founded in 2014 to translate over 20 years of CAR-T research led by Dr. John Maher at King's College London, Leucid has developed a proprietary Lateral CAR platform. This platform redesigns CAR structures to mimic natural immune receptor configurations, enhancing T-cell potency and persistence while reducing toxicity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
3rd Floor, Bermondsey Wing Guy's Hospital London SE1 9RT
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-10/leucid-bio-provides-update-on-phase-iiia-aerial-trial-evaluating-lateral-car-t-leu011-for-the-treatment-of-solid-tumours

PHARMIWEB
10 Nov 2025

https://www.prnewswire.com/news-releases/leucid-bio-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302540262.html

PR NEWSWIRE
28 Aug 2025

https://www.prnewswire.com/news-releases/leucid-bio-appoints-filippo-petti-as-chief-executive-officer-301878702.html

PR NEWSWIRE
18 Jul 2023

https://www.prnewswire.com/news-releases/leucid-bio-and-great-ormond-street-hospital-enter-commercial-agreement-at-new-gene-therapy-manufacturing-centre-301773376.html

PR NEWSWIRE
16 Mar 2023

https://www.prnewswire.com/news-releases/leucid-bio-provides-business-update-and-outlook-for-2023-301748526.html

PR NEWSWIRE
16 Feb 2023

https://www.pharmacompass.com/pdf/news/leucid-bio-lonza-enter-strategic-collaboration-to-leverage-the-cocoon-platform-1641199058.pdf

PRESS RELEASE
02 Dec 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty